Radiotherapy and gemcitabine–docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma

JA Lee, EK Paik, J Seo, DH Kim, JS Lim… - Japanese journal of …, 2016 - academic.oup.com
Objective Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …

Radiotherapy and gemcitabine--docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.

JA Lee, EK Paik, J Seo, DH Kim… - … Journal of Clinical …, 2016 - search.ebscohost.com
Objective: Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …

Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma

JA Lee, EK Paik, J Seo, DH Kim… - … journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …

Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma

JA Lee, EK Paik, J Seo, DH Kim, JS Lim… - Japanese Journal of …, 2016 - hero.epa.gov
OBJECTIVE: Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …

Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.

JA Lee, EK Paik, J Seo, DH Kim, JS Lim… - Japanese Journal of …, 2015 - europepmc.org
Objective Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …